Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anna Prilenskaya"'
Autor:
Evgeniy Evdoshenko, Alexandra Stepanova, Maria Shumilina, Maria Davydovskaya, Natalia Khachanova, Nikolay Neofidov, Ivan Kalinin, Ekaterina Popova, Ekaterina Dubchenko, Natalia Pozhidaeva, Andrey Volkov, Stella Sivertseva, Anna Prilenskaya, Nadezhda Malkova, Denis Korobko, Ilona Vergunova, Sergey Shchur, Gleb Makshakov
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217303 (2019)
BackgroundNTZ is approved in Russia for the treatment of highly active relapsing remitting multiple sclerosis and is reimbursed via federal budget program. However, no data about NTZ treatment in Russia and the effect of federal reimbursement have be
Externí odkaz:
https://doaj.org/article/5d0bf15288324e78ba2dafd9cff30116
Autor:
Ilona Vergunova, S A Sivertseva, Khachanova Nv, Anna Prilenskaya, Ekaterina Dubchenko, Natalia Pozhidaeva, D. S. Korobko, Alexandra Stepanova, M. V. Davydovskaya, Nikolay Neofidov, Ekaterina Popova, Andrey Volkov, Shchur Sg, Gleb Makshakov, M. V. Shumilina, N A Malkova, Ivan Kalinin, E. P. Evdoshenko
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 5, p e0217303 (2019)
PLoS ONE, Vol 14, Iss 5, p e0217303 (2019)
BackgroundNTZ is approved in Russia for the treatment of highly active relapsing remitting multiple sclerosis and is reimbursed via federal budget program. However, no data about NTZ treatment in Russia and the effect of federal reimbursement have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf437ac617f5c8a63b9f7a851c0a46bd
https://doi.org/10.1371/journal.pone.0217303
https://doi.org/10.1371/journal.pone.0217303